As depicted in Figure 2(Fig. 2), the results revealed that the NEAT1 and BC200 levels in the plasma samples of the AD patients were significantly higher compared with the control group (p=0.0021 and p=0.02, respectively, Figure 2a and 2b(Fig. 2)). Here, BCYRN1 is linked to Alzheimer disease.